Supporting this hypothesis, studies by Fujii, et al. [76], Kodach, et al. [77], and Ciavatta, et al. [78] demonstrate that RUNX3 repression in human cancers and diseases such as vasculitis enables increased tumorigenesis. This evidence concerns the gene RUNX3 and cancer.